Dow Down1.17% Nasdaq Down1.19%

AMAG Pharmaceuticals, Inc. (AMAG)

-NasdaqGS
27.43 Down 0.23(0.83%) Apr 28, 4:00PM EDT
|After Hours : 27.43 0.00 (0.00%) Apr 28, 4:28PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
Total Revenue 418,276   124,384   80,856  
Cost of Revenue88,501  20,306  11,960  
Gross Profit 329,775   104,078   68,896  
Operating Expenses
Research Development42,878  24,160  20,564  
Selling General and Administrative160,309  72,254  59,167  
Non Recurring15,368  11,501  782  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 111,220   (3,837) (11,617)
Income from Continuing Operations
Total Other Income/Expenses Net(18,125)1,192  2,015  
Earnings Before Interest And Taxes93,095  (2,645)(9,602)
Interest Expense53,251  14,697   -  
Income Before Tax39,844  (17,342)(9,602)
Income Tax Expense7,065  (153,159) -  
Minority Interest -   -   -  
Net Income From Continuing Ops32,779  135,817  (9,602)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 32,779   135,817   (9,602)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 32,779   135,817   (9,602)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.